Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | EDNRB | P24530 | 1/20 | 0.32 |
| ▸ | EDNRA | P25101 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | RAC2 | P15153 | 1/20 | 0.31 |
| ▸ | RAC3 | P60763 | 1/20 | 0.31 |
| ▸ | CDC42 | P60953 | 1/20 | 0.31 |
| ▸ | RAC1 | P63000 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13427963 | 1.00 | KDM4E (0.35) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL13428065 | 0.99 | KDM4E (0.34) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL13427972 | 0.97 | PDK2 (0.33) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL13427944 | 0.96 | KDM4E (0.34) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL13669819 | 0.96 | KDM4E (0.34) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL13428285 | 0.96 | KDM4E (0.34) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL13428081 | 0.95 | KDM4E (0.33) | KDM4EATML3MBTL1EDNRBEDNRA | |
| SCHEMBL13427970 | 0.95 | KDM4E (0.33) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL13427961 | 0.94 | PDK2 (0.33) | KDM4EATML3MBTL1PDK2 | |
| SCHEMBL13428074 | 0.94 | PDK2 (0.33) | KDM4EATML3MBTL1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | RPL36, RPL39, RPL36A | KDM4E 4138/4885ATM 4252/4885L3MBTL1 1117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.